Care Transition Intervention for Patients With Cancer
1 other identifier
interventional
58
1 country
1
Brief Summary
This research study is investigating an intervention called CONTINUity of care Under Management by Video visits (CONTINUUM-V). CONTINUUM-V involves a video visit with an oncology nurse practitioner within three business days of hospital discharge for patients with advanced cancer with the goal of reducing burdensome care transitions after hospitalization, including hospital readmissions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 11, 2020
CompletedFirst Posted
Study publicly available on registry
November 23, 2020
CompletedStudy Start
First participant enrolled
January 7, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 14, 2021
CompletedNovember 19, 2021
November 1, 2021
5 months
November 11, 2020
November 11, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility using enrollment and retention on study
The intervention will be deemed feasible if at least 70% of eligible patients participate in the study, and if at least 70% complete the video visit within three business days of discharge.
Discharge to 3 business days
Secondary Outcomes (4)
Patients' Confidence in Managing their Health Condition using the Patient Activation Measure (PAM-13)
Baseline to 15 days after discharge
Symptom Burden using the Edmonton Symptom Assessment Scale (ESAS-r)
Baseline to 15 days after discharge
Psychological Symptoms using the Patient Health Questionnaire-4 (PHQ-4)
Baseline to 15 days after discharge
Patient Satisfaction using the Patient Satisfaction Questionnaire
10 to 15 days after discharge
Other Outcomes (1)
30-day Hospital Readmissions
Discharge to 30 days after discharge
Study Arms (1)
CONTINUity of care Under Management by Video visits (CONTINUUM-V)
EXPERIMENTALParticipants with advanced cancer will receive a video visit conducted by an oncology Nurse Practitioner (NP) within three (3) business days of hospital discharge. The visit will involve: (1) reconcile medications, (2) manage symptoms, (3) review the post-hospital care plan for hospitalization-specific issues, and (4) schedule follow-up with the outpatient oncology team. Participant and clinician may also be interviewed for their feedback on the video visit. The ultimate goal of the intervention is to improve patients' confidence in managing their health condition and reduce burdensome health care utilization after discharge, particularly reducing 30-day hospital readmissions.
Interventions
Video visit by nurse practitioner within 3 business days of hospital discharge.
Eligibility Criteria
You may qualify if:
- Age \>= 18 years
- Unplanned admission to the oncology service at Massachusetts General Hospital (MGH)
- Known diagnosis of advanced breast, thoracic, genitourinary, or gastrointestinal cancers. Advanced cancer defined as not being treated with curative intent as determined by clinic notes and chemotherapy order entry.
- Receiving ongoing oncology care at MGH
- Verbal fluency in English
- Must have internet/wifi/cellular data access
You may not qualify if:
- Admitted electively
- Discharged to a location other than home or expired during admission
- Discharged with hospice services
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer S Temel, MD
Massachusetts General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 11, 2020
First Posted
November 23, 2020
Study Start
January 7, 2021
Primary Completion
May 28, 2021
Study Completion
July 14, 2021
Last Updated
November 19, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Data can be shared no earlier than 1 year following the date of publication
- Access Criteria
- Contact the Partners Innovations team at http://www.partners.org/innovation
The Dana-Farber / Harvard Cancer Center encourages and supports the responsible and ethical sharing of data from clinical trials. De-identified participant data from the final research dataset used in the published manuscript may only be shared under the terms of a Data Use Agreement. Requests may be directed to: \[contact information for Sponsor Investigator or designee\]. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.